HOLX Hologic Inc

Price (delayed)

$76.865

Market cap

$18.04B

P/E Ratio

36.26

Dividend/share

N/A

EPS

$2.12

Enterprise value

$18.69B

Hologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnostics, surgery, and medical imaging. In late November 2013, activist investor Carl Icahn ...

Highlights
The company's debt fell by 9% YoY and by 9% QoQ
Hologic's net income has decreased by 48% YoY but it has increased by 13% QoQ
The EPS has declined by 46% year-on-year but it is up by 15% since the previous quarter
The stock's price to earnings (P/E) is 30% more than its 5-year quarterly average of 28.0 and 4.6% more than its last 4 quarters average of 34.8
The gross profit has contracted by 23% YoY and by 2.4% from the previous quarter

Key stats

What are the main financial stats of HOLX
Market
Shares outstanding
234.73M
Market cap
$18.04B
Enterprise value
$18.69B
Valuations
Price to book (P/B)
3.96
Price to sales (P/S)
4.62
EV/EBIT
25.35
EV/EBITDA
17.58
EV/Sales
4.71
Earnings
Revenue
$3.97B
EBIT
$737.3M
EBITDA
$1.06B
Free cash flow
$858.7M
Per share
EPS
$2.12
Free cash flow per share
$3.6
Book value per share
$19.39
Revenue per share
$16.63
TBVPS
$18.15
Balance sheet
Total assets
$8.47B
Total liabilities
$3.82B
Debt
$2.58B
Equity
$4.65B
Working capital
$2.6B
Liquidity
Debt to equity
0.55
Current ratio
3.89
Quick ratio
2.9
Net debt/EBITDA
0.61
Margins
EBITDA margin
26.8%
Gross margin
50.9%
Net margin
13%
Operating margin
14.9%
Efficiency
Return on assets
5.7%
Return on equity
10.2%
Return on invested capital
18%
Return on capital employed
9.7%
Return on sales
18.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HOLX stock price

How has the Hologic stock price performed over time
Intraday
-0.42%
1 week
2.6%
1 month
2.13%
1 year
-10.23%
YTD
7.58%
QTD
-1.4%

Financial performance

How have Hologic's revenue and profit performed over time
Revenue
$3.97B
Gross profit
$2.02B
Operating income
$591M
Net income
$515.1M
Gross margin
50.9%
Net margin
13%
Hologic's operating income has shrunk by 52% YoY and by 10% QoQ
Hologic's net income has decreased by 48% YoY but it has increased by 13% QoQ
The operating margin has contracted by 46% YoY and by 8% from the previous quarter
The company's net margin fell by 41% YoY but it rose by 15% QoQ

Growth

What is Hologic's growth rate over time

Valuation

What is Hologic stock price valuation
P/E
36.26
P/B
3.96
P/S
4.62
EV/EBIT
25.35
EV/EBITDA
17.58
EV/Sales
4.71
The EPS has declined by 46% year-on-year but it is up by 15% since the previous quarter
The stock's price to earnings (P/E) is 30% more than its 5-year quarterly average of 28.0 and 4.6% more than its last 4 quarters average of 34.8
HOLX's price to book (P/B) is 13% lower than its 5-year quarterly average of 4.6 but 8% higher than its last 4 quarters average of 3.7
HOLX's equity is down by 9% year-on-year and by 7% since the previous quarter
HOLX's price to sales (P/S) is 19% higher than its 5-year quarterly average of 3.9
The revenue has contracted by 11% YoY

Efficiency

How efficient is Hologic business performance
The ROE has contracted by 49% YoY but it has grown by 15% from the previous quarter
Hologic's return on assets has decreased by 46% YoY but it has increased by 16% QoQ
HOLX's return on invested capital is down by 43% year-on-year and by 6% since the previous quarter
The return on sales has declined by 36% year-on-year and by 4.6% since the previous quarter

Dividends

What is HOLX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HOLX.

Financial health

How did Hologic financials performed over time
The total assets is 122% higher than the total liabilities
Hologic's current ratio has increased by 12% from the previous quarter but it has decreased by 8% YoY
Hologic's quick ratio has decreased by 11% YoY but it has increased by 4.7% QoQ
The company's debt is 45% lower than its equity
HOLX's equity is down by 9% year-on-year and by 7% since the previous quarter
The company's debt fell by 9% YoY and by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.